Given the importance of IDO-1 for the remission of MS and EAE (reviewed in [85]) and the striking data on the sCD83/IDO-1 axis (see above), it is conceivable that sCD83 secretion represents a counter-mechanism in MS pathology, acting via IDO-1. The gene discussed is IDO1; the disease is myeloid sarcoma.